Triumph Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $574K | Sell |
12,399
-13,828
| -53% | -$640K | 0.17% | 148 |
|
|
2025
Q1 | $1.6M | Buy |
26,227
+20,715
| +376% | +$1.26M | 0.53% | 42 |
|
|
2024
Q4 | $312K | Sell |
5,512
-182
| -3% | -$10.3K | 0.11% | 209 |
|
|
2024
Q3 | $295K | Sell |
5,694
-10,332
| -64% | -$535K | 0.11% | 209 |
|
|
2024
Q2 | $666K | Buy |
16,026
+1,865
| +13% | +$77.5K | 0.26% | 89 |
|
|
2024
Q1 | $750K | Buy |
14,161
+374
| +3% | +$19.8K | 0.31% | 84 |
|
|
2023
Q4 | $707K | Buy |
13,787
+8,605
| +166% | +$442K | 0.3% | 75 |
|
|
2023
Q3 | $301K | Buy |
5,182
+1,464
| +39% | +$85K | 0.14% | 153 |
|
|
2023
Q2 | $238K | Buy |
+3,718
| New | +$238K | 0.11% | 180 |
|